Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Esophageal Carcinoma”

259 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 259 results

Testing effectiveness (Phase 2)Study completedNCT00003192
What this trial is testing

Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
University of Chicago 15
Testing effectiveness (Phase 2)Looking for participantsNCT07290010
What this trial is testing

The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital 25
Testing effectiveness (Phase 2)UnknownNCT03927495
What this trial is testing

KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 100
Not applicableUnknownNCT05900583
What this trial is testing

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Who this might be right for
Minimal Residual DiseaseEsophageal Squamous Cell Carcinoma
Guangdong Provincial People's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00020761
What this trial is testing

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142421
What this trial is testing

Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
First Affiliated Hospital of Zhejiang University 35
Testing effectiveness (Phase 2)Study completedNCT00281736
What this trial is testing

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Who this might be right for
Esophageal CancerPrecancerous Condition
Roswell Park Cancer Institute 60
Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT01498289
What this trial is testing

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
SWOG Cancer Research Network 213
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Not applicableUnknownNCT03713749
What this trial is testing

Robotic-assisted Esophagectomy vs. Video-Assisted Thoracoscopic Esophagectomy(REVATE) Trial

Who this might be right for
Esophageal Squamous Cell Carcinoma
Chang Gung Memorial Hospital 212
Testing effectiveness (Phase 2)UnknownNCT03011255
What this trial is testing

Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsEsophageal DiseasesDigestive System Diseases
Shixiu Wu 20
Testing effectiveness (Phase 2)Study completedNCT00264433
What this trial is testing

The Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT03731442
What this trial is testing

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

Who this might be right for
Esophageal Cancer
Chinese Academy of Medical Sciences 300
Early research (Phase 1)WithdrawnNCT00025532
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+1 more
University of California, San Francisco
Testing effectiveness (Phase 2)Study completedNCT00045526
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Ended earlyNCT03709706
What this trial is testing

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

Who this might be right for
Neoplasms
GlaxoSmithKline 34
Testing effectiveness (Phase 2)Study completedNCT00381706
What this trial is testing

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 245
Testing effectiveness (Phase 2)Study completedNCT00607594
What this trial is testing

Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the StomachRecurrent Gastric Cancer+4 more
National Cancer Institute (NCI) 21
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Next Page